Why Nephrologists Need to Think Twice About Phosphorus Management
Jay Wish MD, professor of clinical medicine at Indiana University School of Medicine and chief medical officer for outpatient dialysis at Indiana University Health, discusses the challenges of maintaining healthy phosphorus levels in patients. Hyperphosphatemia, or an electrolyte disorder in which there is an elevated level of phosphate in the blood, can cause serious cardiac conditions. In this episode, he discusses the current challenges in care, his recent peer-reviewed data on phosphate management and the latest research on potential new solutions on the horizon for CKD patients in need. This discussion comes just ahead of ASN’s Kidney Week where there will be new data on the impact of hyperphosphatemia on CKD patients and potential new treatments.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Treatment. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Treatment and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Treatment?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Jay Wish MD, professor of clinical medicine at Indiana University School of Medicine and chief medical officer for outpatient dialysis at Indiana University Health, discusses th…
- Key Point: Hyperphosphatemia, or an electrolyte disorder in which there is an elevated level of phosphate in the blood, can cause serious cardiac conditions.
- Key Point: In this episode, he discusses the current challenges in care, his recent peer-reviewed data on phosphate management and the latest research on potential new solutions on the hor…
- Key Point: This discussion comes just ahead of ASN’s Kidney Week where there will be new data on the impact of hyperphosphatemia on CKD patients and potential new treatments.
- Key Point: Wish, MD is Medical Director of the Out-Patient Dialysis Unit at Indiana University Hospital, Chief Medical Officer for Dialysis at IU Health, and Professor of Clinical Medicine…
Jay B. Wish, MD is Medical Director of the Out-Patient Dialysis Unit at Indiana University Hospital, Chief Medical Officer for Dialysis at IU Health, and Professor of Clinical Medicine at Indiana University School of Medicine. He is past president of the National Forum of ESRD Networks and was the lead nephrology consultant to the Fistula First Breakthrough Initiative 2009-2012. He served on the Board of Directors of the Renal Physicians Association and the American Association of Kidney Patients and was the recipient of the latter’s Visionary Award in 2005. Dr. Wish is Vice Chairman of the Editorial Advisory Board for Nephrology News & Issues and is on the editorial boards of the Clinical Journal of the American Society of Nephrology and the Journal of the American Society of Nephrology. He has had numerous articles, editorials, reviews, and book chapters published, particularly in the areas of End-Stage Kidney Disease quality oversight/improvement, accountability, anemia management and vascular access.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



